Cluster1 was enriched in cancer‐related pathways, including the mTOR signaling pathway, Notch signaling pathway, and cell cycle, whereas cluster2 was enriched in pathways related to metabolism‐related pathways, consisting of amino acid metabolism, lipid metabolism, glucose metabolism, and drug metabolism (Figure 2C). This evidence concerns the gene MTOR and cancer.